Next-generation immune checkpoint inhibitors as promising functional molecules in cancer therapeutics

Anupam Dhasmana^{1

2}, Swati Dhasmana^{1

2}, Shafiul Haque^{3

4

5}, Everardo Cobos⁶, Murali M Yallapu^{1

2}, Subhash C Chauhan^{7

8}

Affiliations

¹ Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX, 78504, USA.
² South Texas Center of Excellence in Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX, USA.
³ Research and Scientific Studies Unit, College of Nursing and Allied Health Sciences, Jazan University, Jazan, Saudi Arabia.
⁴ Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Beirut, Lebanon.
⁵ Centre of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates.
⁶ Department of Medicine, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX, USA.
⁷ Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX, 78504, USA. subhash.chauhan@utrgv.edu.
⁸ South Texas Center of Excellence in Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX, USA. subhash.chauhan@utrgv.edu.

Editorial

Anupam Dhasmana et al. Cancer Metastasis Rev. 2023 Sep.

. 2023 Sep;42(3):597-600.

doi: 10.1007/s10555-023-10139-6.

Anupam Dhasmana^{1

2}, Swati Dhasmana^{1

2}, Shafiul Haque^{3

4

5}, Everardo Cobos⁶, Murali M Yallapu^{1

2}, Subhash C Chauhan^{7

8}

¹ Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX, 78504, USA.
² South Texas Center of Excellence in Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX, USA.
³ Research and Scientific Studies Unit, College of Nursing and Allied Health Sciences, Jazan University, Jazan, Saudi Arabia.
⁴ Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Beirut, Lebanon.
⁵ Centre of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates.
⁶ Department of Medicine, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX, USA.
⁷ Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX, 78504, USA. subhash.chauhan@utrgv.edu.
⁸ South Texas Center of Excellence in Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX, USA. subhash.chauhan@utrgv.edu.

No abstract available

References

1. Dhasmana, A., Dhasmana, S., Kotnala, S., Anukriti, A., Kashyap, V. K., Shaji, P. D., et al. (2022). A topography of immunotherapies against gastrointestinal malignancies. Panminerva Med, 64(1), 56–71. https://doi.org/10.23736/s0031-0808.21.04541-9
1. He, X., & Xu, C. (2020). Immune checkpoint signaling and cancer immunotherapy. Cell Research, 30(8), 660–669. https://doi.org/10.1038/s41422-020-0343-4 - DOI - PubMed - PMC
1. Gaikwad, S., Agrawal, M. Y., Kaushik, I., Ramachandran, S., & Srivastava, S. K. (2022). Immune checkpoint proteins: Signaling mechanisms and molecular interactions in cancer immunotherapy. Seminars in Cancer Biology, 86, 137–150. https://doi.org/10.1016/j.semcancer.2022.03.014 - DOI - PubMed
1. Ge, S., Jia, T., Li, J., Zhang, B., Deng, S., & Sang, S. (2022). Molecular imaging of immune checkpoints in oncology: current and future applications. Cancer Letters, 548, 215896. https://doi.org/10.1016/j.canlet.2022.215896 - DOI - PubMed
1. Schöffski, P., Tan, D. S. W., Martín, M., Ochoa-de-Olza, M., Sarantopoulos, J., Carvajal, R. D., et al. (2022). Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies. J Immunother Cancer, 10(2). https://doi.org/10.1136/jitc-2021-003776